L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
ATC group of level 4 – chemical subgroup · in plain English: targeted cancer medicines (kinase inhibitors)
This site has the patient leaflet or the SPC of 40 medicines in this group and its subgroups.
- 33 prescription only (POM)
- 7 no longer supplied or not available
Place in the ATC classification
- L Antineoplastic and immunomodulating agents 1,791 medicines
- L01 Antineoplastic agents 1,025 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
-
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01EB01 gefitinib 6 medicines
- L01EB02 erlotinib 25 medicines
- L01EB03 afatinib 4 medicines
- L01EB04 osimertinib 2 medicines
- L01EB07 dacomitinib 3 medicines
-
L01EB Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors 40 medicines
- L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents 353 medicines
- L01 Antineoplastic agents 1,025 medicines
3 more subgroups have no medicine with a leaflet on this site.
Active substances in the group
- Afatinib 4 medicines
- Dacomitinib 3 medicines
- Erlotinib 25 medicines
- Gefitinib 6 medicines
- Osimertinib 2 medicines
Medicines in the group and its subgroups
Other groups of the same level
- L01EA BCR-ABL tyrosine kinase inhibitors 101 medicines
- L01EC B-Raf serine-threonine kinase (BRAF) inhibitors 6 medicines
- L01ED Anaplastic lymphoma kinase (ALK) inhibitors 14 medicines
- L01EE Mitogen-activated protein kinase (MEK) inhibitors 10 medicines
- L01EF Cyclin-dependent kinase (CDK) inhibitors 13 medicines
- L01EG Mammalian target of rapamycin (mTOR) kinase inhibitors 27 medicines
- L01EH Human epidermal growth factor receptor 2 (HER2) tyrosine kinase inhibitors 4 medicines
- L01EJ Janus-associated kinase (JAK) inhibitors 18 medicines
- L01EK Vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors 12 medicines
- L01EL Bruton's tyrosine kinase (BTK) inhibitors 8 medicines
- L01EM Phosphatidylinositol-3-kinase (Pi3K) inhibitors 6 medicines
- L01EX Other protein kinase inhibitors 94 medicines
Other names of the ATC group
- German: L01EB Epidermaler Wachstumsfaktor-Rezeptor (EGFR)-Tyrosinkinase-Inhibitoren
- German: L01EB Epidermaler Wachstumsfaktor-Rezeptor (EGFR)-Tyrosinkinase-Inhibitoren
- Italian: L01EB Inibitore del recettore per il fattore di crescita epidermico (EGFR)
- Turkish: L01EB Epidermal büyüme faktörü reseptörü (EGFR) tirozin kinaz inhibitörleri
- Czech: L01EB Tyrosinkinázové inhibitory receptoru pro epidermální růstový faktor (EGFR)
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group L01EB
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.